Founded to advance artificial intelligence for health, our group unites expertise in computer science, mathematics, and medical sciences to translate innovation into clinical impact through collaborations with academic and industry partners since 2022.

We cover the full research cycle—from rigorous planning and innovative execution to transparent reporting.

Our patient‑centred approach prioritizes ethical AI for early diagnosis, clinical decision support, and personalized monitoring, and is driven by international projects with a vision of social impact, inclusivity, and scientific excellence.

Led by Daniele Ravì (University of Messina), the multidisciplinary team includes:

• Lemuel Puglisi (PhD, University of Catania) – Computer Scientist
• Antonio Scardace (PhD, University of Catania) – Computer Scientist
• Dr. Abdul Raouf Mastan (University of Messina) – Medical Doctor
  
• David Poland (D.Eng., University of Hertfordshire) – Engineer

We lead cutting‑edge projects in AI, generative models, and medical imaging diagnostics, with partners in Italy and abroad.

Our international experience enables innovative digital health solutions focused on:

• Neurodegenerative disease progression
• Clinical data quality
• Generative models for diagnosis and patient monitoring